electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th
Conference ID: 748491
Webcast: electroCore 2Q21 Business Update Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Rich Cockrell CG Capital404-736-3838 firstname.lastname@example.org or Media Contact: Jackie DorskyelectroCore 908-313-6331 Jackie.email@example.com